Last10K.com

America Great Health (AAGH) SEC Filing 10-Q Quarterly Report for the period ending Friday, September 30, 2022

SEC Filings

AAGH Quarterly Reports

America Great Health

CIK: 1098009 Ticker: AAGH
Document And Entity Information - shares
3 Months Ended
Sep. 30, 2022
Feb. 08, 2023
Document Information Line Items  
Entity Registrant NameAmerica Great Health 
Trading SymbolN/A 
Document Type10-Q 
Current Fiscal Year End Date--06-30 
Entity Common Stock, Shares Outstanding 21,090,218,148
Amendment Flagfalse 
Entity Central Index Key0001098009 
Entity Current Reporting StatusNo 
Entity Filer CategoryNon-accelerated Filer 
Document Period End DateSep. 30, 2022 
Document Fiscal Year Focus2023 
Document Fiscal Period FocusQ1 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Entity File Number000-27873 
Entity Incorporation, State or Country CodeWY 
Entity Tax Identification Number98-0178621 
Entity Address, Address Line One1609 W Valley Blvd Unit 338A 
Entity Address, City or TownAlhambra 
Entity Address, State or ProvinceCA 
Entity Address, Postal Zip Code91803 
City Area Code888 
Local Phone Number988-1333 
Title of 12(b) SecurityN/A 
Security Exchange NameNONE 
Entity Interactive Data CurrentNo 

View differences made from one quarter to another to evaluate America Great Health's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by America Great Health.

Continue

Assess how America Great Health's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

America Great Health's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statement Of Changes In Shareholders' Deficit
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Accounting Policies, By Policy (Policies)
Concentration
Concentration (Details) - Schedules Of Concentration Of Risk, By Risk Factor
Concentration (Tables)
Convertible, Redeemable Preferred Stock
Convertible, Redeemable Preferred Stock (Details)
Deposits
Deposits (Details)
Deposits (Details) - Schedule Of Accounts, Notes, Loans And Financing Receivable
Deposits (Tables)
Equity Investment
Equity Investment (Details)
Equity Investment (Details) - Equity Method Investments
Equity Investment (Details) - Equity Method Investments (Parentheticals)
Equity Investment (Tables)
Income Taxes
Income Taxes (Details)
Inventory
Inventory (Details) - Schedule Of Inventory, Current
Inventory (Tables)
Lease
Lease (Details)
Lease (Details) - Lease, Cost
Lease (Details) - Lessee, Operating Lease, Liability, Maturity
Lease (Tables)
Long Term Loan
Long Term Loan (Details)
Long Term Loan (Details) - Schedule Of Long-Term Debt Instruments
Long Term Loan (Details) - Schedule Of Long-Term Debt Instruments (Parentheticals)
Long Term Loan (Tables)
Nature Of Business
Nature Of Business (Details)
Related Party Transactions
Related Party Transactions (Details)
Shareholders' Deficit
Shareholders' Deficit (Details)
Short Term Loan
Short Term Loan (Details)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Details) - Schedule Of Differences Between Reported Amount And Reporting Currency Denominated Amount
Summary Of Significant Accounting Policies (Details) - Schedule Of Subsidiaries
Summary Of Significant Accounting Policies (Tables)

Material Contracts, Statements, Certifications & more

America Great Health provided additional information to their SEC Filing as exhibits

Ticker: AAGH
CIK: 1098009
Form Type: 10-Q Quarterly Report
Accession Number: 0001185185-23-000110
Submitted to the SEC: Wed Feb 08 2023 5:09:18 PM EST
Accepted by the SEC: Wed Feb 08 2023
Period: Friday, September 30, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aagh/0001185185-23-000110.htm